Letter to the Editor
Continued Response to One Dose of Nivolumab Complicated by Myasthenic Crisis and Myositis

https://doi.org/10.1016/j.jtho.2017.02.024Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Disclosure: The authors declare no conflict of interest.